Xilio Therapeutics secures funding, focuses on advancing immuno-oncology therapies
From Globe Newswire: 2024-03-28 07:05:00 Xilio Therapeutics is making strategic changes to focus on advancing clinical-stage programs for tumor-activated immuno-oncology
